This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Register to attend this important, free Manufacturing Challenges Facing Cell & Gene Therapy webinar
As more regenerative medicine products approach clinical testing and commercialization, stakeholders in the field are increasingly pressed to address substantial obstacles, including:
Pricing and reimbursement
Attendees will hear detailed insights and industry best practices from preeminent sector experts and will take away a deeper understanding of and appreciation for manufacturing and various industrialization hurdles unique to bringing durable, potentially curative therapies to patients in need.
The speakers will discuss pressing issues such as how sponsors move from a smaller process to a larger one; whether to approach manufacturing by building in-house, outsourced or hybrid capabilities; key logistical challenges; as well as a deeper dive into specific manufacturing issues facing autologous cell therapies.
Ph.D., CEO and President, Hitachi Chemical Advanced Therapeutic Solutions, LLC; General Manager, Hitachi Chemical Regenerative Medicine Business Sector